KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Cash from Financing Activities (2019 - 2025)

Clover Health Investments (CLOV) has disclosed Cash from Financing Activities for 7 consecutive years, with -$5.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Financing Activities fell 12.97% year-over-year to -$5.3 million, compared with a TTM value of -$50.9 million through Sep 2025, down 322.7%, and an annual FY2024 reading of -$17.4 million, down 242.43% over the prior year.
  • Cash from Financing Activities was -$5.3 million for Q3 2025 at Clover Health Investments, up from -$7.8 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $662.5 million in Q1 2021 and bottomed at -$31.7 million in Q1 2025.
  • Average Cash from Financing Activities over 5 years is $44.9 million, with a median of -$2.1 million recorded in 2023.
  • The sharpest move saw Cash from Financing Activities soared 151356.62% in 2021, then tumbled 2073.47% in 2024.
  • Year by year, Cash from Financing Activities stood at $284.4 million in 2021, then plummeted by 99.98% to $56000.0 in 2022, then crashed by 1575.0% to -$826000.0 in 2023, then plummeted by 643.46% to -$6.1 million in 2024, then increased by 14.17% to -$5.3 million in 2025.
  • Business Quant data shows Cash from Financing Activities for CLOV at -$5.3 million in Q3 2025, -$7.8 million in Q2 2025, and -$31.7 million in Q1 2025.